This finding aligns with the observation that aggressive breast cancer subtypes, such as IBC, are often HER2-positive and hormone-insensitive (ER/PR-low), suggesting that MARCKS may contribute to the hormone receptor-negative phenotype observed in these tumors. This evidence concerns the gene MARCKS and breast cancer.